- Report
- December 2025
- 150 Pages
Global
From €5269EUR$5,950USD£4,515GBP
- Report
- October 2025
- 120 Pages
Global
From €5269EUR$5,950USD£4,515GBP
- Report
- May 2026
- 147 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- April 2026
- 149 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- April 2026
- 135 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- April 2026
- 137 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- April 2026
- 140 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- April 2026
- 142 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- March 2026
- 140 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- March 2026
- 136 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- February 2026
- 141 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- February 2026
- 295 Pages
Global
From €2214EUR$2,500USD£1,897GBP
- Report
- May 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- August 2026
- 310 Pages
Global
From €5180EUR$5,850USD£4,439GBP
- Report
- August 2026
- 224 Pages
Global
From €5180EUR$5,850USD£4,439GBP
- Report
- August 2026
- 374 Pages
Global
From €5180EUR$5,850USD£4,439GBP
- Report
- August 2026
- 285 Pages
Global
From €5180EUR$5,850USD£4,439GBP
- Report
- August 2026
- 419 Pages
Global
From €5180EUR$5,850USD£4,439GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more